Forte Biosciences, Inc. Ratios

Ratios Dec2015 Dec2016 Dec2017 Dec2018 Dec2019
Profitability
EBT Margin 8,044.10%-68,320.41%-94,946.34%-262.01%-176,430.56%
EBIT Margin 7,970.14%-64,673.47%-91,775.61%-254.23%-170,863.89%
EBITDA Margin 8,023.61%-68,204.08%-95,031.71%-271.37%-176,341.67%
Operating Margin 7,970.14%-64,673.47%-91,775.61%-254.23%-170,863.89%
Net Margin 8,044.10%-68,322.45%-94,948.78%-271.43%-176,433.33%
FCF Margin 7,386.46%-61,355.10%-77,531.71%-202.02%-8,147.22%
Efficiency
Assets Average 63.71M97.58M55.37M
Equity Average -26.67M64.61M26.69M
Invested Capital -124.42M71.08M58.15M-4.77M
Asset Utilization Ratio 0.000.180.00
Leverage & Solvency
Interest Coverage Ratio -67.71-15.44-19.48-15.65-16.10
Debt to Equity -0.080.050.45
Debt Ratio 0.290.040.25
Equity Ratio -3.520.770.56-0.62
Times Interest Earned -67.71-15.44-19.48-15.65-16.10
Valuation
Enterprise Value -5.51M167.11M123.00M5.80M
Market Capitalization 203.05M163.82M12.74M
Return Ratios
Return on Sales 80.44%-683.22%-949.49%-2.71%
Return on Capital Employed -0.81%-0.57%-1.15%
Return on Assets -0.61%-0.50%-1.15%
Return on Equity 1.46%-0.76%-2.38%